SCHEMBL24534516

SCHEMBL24534516

C=C1N=C(c2ccc(Oc3ccccc3)cc2)OC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.46
NPC1 O15118 4/20 0.41
RAB9A P51151 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
MMP9 P14780 1/20 0.41
LTA4H P09960 3/20 0.41
TLR8 Q9NR97 1/20 0.41
ALOX5 P09917 1/20 0.40
NISCH Q9Y2I1 1/20 0.40
CSNK2A2 P19784 2/20 0.39
CSNK2B P67870 2/20 0.39
CSNK2A1 P68400 2/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TNNI3 P19429 1/20 0.39
CRHBP P24387 1/20 0.39
TNNT2 P45379 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24534659 0.84 SMN1; SMN2 (0.47) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL2714415 0.84 SMN1; SMN2 (0.50) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL24534553 0.82 ALOX5 (0.48) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL24534663 0.81 GSTP1 (0.52) GSTP1NPC1RAB9AMEN1KMT2A
SCHEMBL24534678 0.78 NOTUM (0.44) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL24534730 0.77 PTGS2 (0.50) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL24534595 0.76 NPC1 (0.50) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL24241617 0.76 CYP2D6 (0.46) NPC1RAB9AMAPTCSNK2A2CSNK2B
SCHEMBL24241587 0.75 ALOX5 (0.53) GSTP1MEN1KMT2AMAPTALOX5
SCHEMBL6797933 0.74 PLCG2 (0.67) NPC1RAB9AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220193041-A1 NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT Yonsei University, University - Industry Foundation (UIF) (KR) 2022-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220193041-A1 NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT EPX, CFTR, MPO GSTP1 470/4885NPC1 47/4885RAB9A 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.